The Indian Medical Association (IMA) has established the National Alliance of Medical Professionals on Antimicrobial Resistance (NAMP-AMR), uniting leaders and representatives from 52 medical specialty organisations nationwide. This alliance aims to address the critical health crisis of Antimicrobial Resistance (AMR), which in 2019 was responsible for 297,000 deaths and associated with over 1 million deaths in India.
“AMR poses a significant threat to the health of our Nation. In 2019, there were 297,000 deaths attributable to AMR and 1,042,500 deaths associated with AMR in our country. The formation of NAMP-AMR by the Indian Medical Association marks the beginning of a concerted National effort to tackle this crisis head-on,” stated Dr Narendra Saini, Chairman of IMA AMR
The government, represented by Dr VK Paul from NITI Aayog, has affirmed its commitment to addressing Antimicrobial Resistance. Dr Paul expressed concern over the potential impact of AMR on Viksit Bharat, including prosperity, GDP, and various health aspects. He applauded IMA’s initiative of NAMP-AMR, describing it as the right step in the right direction. Dr Paul emphasised the necessity of uniting all organisations under one banner to turn this into a national movement.
Payden, Deputy Head of WHO India, emphasised the global urgency of addressing AMR and projected it as a potential leading cause of death by 2050. She stressed the importance of a collaborative approach to this global threat. Dr Anuj Sharma, Team focal point for AMR & IPC, WHO, expressed gratitude to all the 52 medical organisations/associations that came together for the formation of NAMP-AMR.
The National Alliance of Medical Professionals on Antimicrobial Resistance (NAMP-AMR) represents a unified commitment to address one of the most pressing health emergencies of our time. Through collaborative efforts, strategic planning, and governmental support, Indian Medical Association’s (IMA’s) National Alliance of Medical Professionals on Antimicrobial Resistance (NAMP-AMR) initiative aims to lead the way in global efforts to mitigate the impact of Antimicrobial Resistance (AMR).